Synstar Japan Malaria Drug Candidate Obtains MMV Research Collaboration
This article was originally published in PharmAsia News
Executive Summary
A new malaria drug compound developed by Japanese drug venture company Synstar Japan has been selected as a research partner by Geneva-based non-profit organization Medicines of Malaria Venture